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At the frontline — Research
According to the WHO protocol, radio-
logically confirmed pneumonia — endpoint
consolidation — is defined as “dense opa-
city . . . fluffy consolidation of a portion or
whole of a lobe or of the entire lung, often
containing ai  bro chograms and sometimes
associated with pleural effusion”.3 We stud-
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shou592ABSTRACT
Objective: To determine the burden of hospitalised, radiologically confirmed pneumonia 
(World Health Organization protocol) in Northern Territory Indigenous children.
Design, setting and participants: Historical, observational study of all hospital 
admissions for any diagnosis of NT resident Indigenous children, aged between 
 29 days and < 5 years, 1 April 1997 to 31 March 2005.
Intervention:  All chest radiographs taken during these admissions, regardless of 
diagnosis, were assessed for pneumonia in accordance with the WHO protocol.
Main outcome measure: The primary outcome was endpoint consolidation (dense 
fluffy consolidation [alveolar infiltrate] of a portion of a lobe or the entire lung) present 
on a chest radiograph within 3 days of hospitalisation.
Results: We analysed data on 24 115 hospitalised episodes of care for 9492 children 
and 13 683 chest radiographs. The average annual cumulative incidence of endpoint 
consolidation was 26.6 per 1000 population per year (95% CI, 25.3–27.9); 57.5 per 1000 
ear in infants aged 1–11 months, 38.3 per 1000 per year in those aged 12–23 
hs, and 13.3 per 1000 per year in those aged 24–59 months. In all age groups, rates 
dpoint consolidation in children in the arid southern region of NT were about twice 
f children in the tropical northern region.
lusion: The rates of severe pneumonia in hospitalised NT Indigenous children are 
g the highest reported in the world. Reducing this unacceptable burden of disease 
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ld be a national health priority.
See also page 586cu
pn
bidA te lower respiratory infections andeumonia are major causes of mor-ity in Indigenous children,1,2 but
systematically evaluated data on the burden
of these diseases are lacking. Most studies of
disease resulting in hospitalisation have relied
on hospital discharge diagnosis codes, which
may be influenced by changes in clinician
practices and coding procedures over time.
In 2001, the World Health Organization
published guidelines for the standardised
measurement in research of radiologically
apparent pneumonia in children.3 These
guidelines are now the benchmark on which
burden of disease and intervention studies
are based.
ied the incidence of hospitalised, radiolo-
gically confirmed pneumonia in Northern
Territory Indigenous children admitted to
hospital over an 8-year period.
METHODS
Design
We conducted a historical observational
study between 1 April 1997 and 31 March
2005 of all NT hospital admissions, irrespec-
tive of diagnosis, of Indigenous children
aged 29 days and < 5 years at the time of
admission. Admissions were excluded if the
child did not reside in the NT, or the location
of residence was unknown or not specified.
All chest x-rays taken during all admissions
were reviewed, but those taken more than
3 days from the date of admission were
excluded as being more likely to represent
nosocomial infections. The primary outcome
was endpoint consolidation seen on a chest
x-ray taken  3 days after admission.
Setting
In 2001, the NT had an estimated resident
population of about 197 800 people4 dis-
persed across 1 346 200 km2; 29% of the
population identify as Aboriginals or Torres
Strait Islanders. Two climate zones exist in
the NT: tropical in the north (the “Top End”)
and arid in the south (the “Centre”). The
average annual population of NT resident
Indigenous children aged between  29
days and < 5 years over the study period was
7214 (range, 7047–7382).
All Indigenous children requiring hospital-
isation are admitted to one of the five public
hospitals in the NT, including those who need
subsequent transfer to larger institutions in
other states. The nearest public hospitals in
other states are hundreds of kilometres from
the NT borders. While not formally docu-
mented, expert opinion indicates that out-of-
hospital deaths in the NT are rare.
X-ray facilities are not available in remote
communities. However, given the high inci-
dence of multiple morbidities in Indigenous
children, clinical algorithms specify that all
Indigenous children admitted to hospital
with respiratory illnesses, gastroenteritis,
malnutrition, failure to thrive and/or anae-
mia have a chest x-ray on admission.
Hospitalisation data
Up to 30 June 1998, the International classi-
fication of diseases, 9th revision, clinical
modification (ICD-9-CM), was used for
morbidity coding of records; for the remain-
ing years, the 10th revision, Australian mod-
ification (ICD-10-AM) was used. Box 1
shows the hierarchy of diagnosis codes
selected. Unique health record numbers
permit linking of data and tracking of indi-
viduals in the NT public hospital system.
Radiological data
All chest x-rays corresponding to inpatient
episodes of care were obtained, de-identi-
fied, and a randomly generated, unique
study number was assigned to each film.
Inpatient episodes of care for which no x-ray
was taken, or the x-ray taken could not be
found, were recorded as “not done”, or
“missing”, respectively.
A panel of seven paediatric and respira-
tory physicians assigned the presence of
endpoint consolidation (yes or no) for eachMJA • Volume 192 Number 10 • 17 May 2010
AT TH E FRONTLINE —  RESEARCHx-ray film, and each film was read inde-
pendently by two readers. An expert panel
consisting of two paediatric radiologists
reviewed films in which there was disagree-
ment about the presence of endpoint con-
solidation or the film’s quality  for
determining this, reading them together for
adjudication. All readers were trained and
their skills calibrated against the set of train-
ing films provided by the WHO; a threshold
of at least 80% agreement with the WHO
diagnosis had to be met by each reader
before commencing study readings. Inter-
observer agreement on the presence of end-
point consolidation was at least 90%.
Readers were blinded to all information
about the episode, discharge diagnosis and
vaccination status. The panel reviewing x-
ray films for which agreement had not been
reached was not aware of the reasons for
disagreement, nor of the identity of the
original readers. An unreadable film was
considered negative for endpoint consoli-
dation.
Statistical analyses
The primary analysis was the cumulative
incidence of endpoint consolidation, strati-
fied by age group of the child and NT health
region, with calculation of incidence rate
ratios. All instances of endpoint consolida-
tion, irrespective of the discharge diagnosis,
were included in the analysis to maximise
the capture of cases and to ensure that the
case definition for the primary analysis was
systematically applied over time. Incidence
rate ratios were computed to compare rates
by NT region and sex. Denominators — the
estimated resident population for each year
of the study — were obtained from the
Australian Bureau of Statistics and the NT
Department of Health and Families. Data
were analysed using Stata SE, version 9.1
(StataCorp, College Station, Tex, USA).
Ethics approval
The study was approved by the joint insti-
tutional Human Research Ethics Commit-
tee of the NT Department of Health and
Community Services and the Menzies
School of Health Research (HREC ID: 02/
63), and by the Human Research Ethics
Committee of Central Australia. Both com-
mittees have Indigenous Health Research
Ethics Subcommittees.
RESULTS
Final dataset
Between 1 April 1997 and 31 March 2005,
there were 24 820 admitted episodes of care
for 9787 Indigenous children (regardless of
NT residence) aged between  29 days and
< 5 years (median age, 2; range, 1–39 epi-
sodes per child). In 10 911 episodes
(43.9%) no chest x-ray was taken, and in 64
episodes (0.3%) the film was missing;
18 224 x-rays were located and assessed for
endpoint consolidation (median, 1; range,
0–142 per episode). The proportion of
admissions in which x-rays were taken
remained stable over the study period (an
average of 56% of all hospitalisations).
Of the 24 820 admitted episodes of care,
705 episodes for 295 children and 4541
chest x-rays were excluded from the analysis
as they did not meet eligibility criteria (child
not an NT resident, x-ray taken  3 days
after admission). The final dataset com-
prised 24 115 admitted episodes of care for
9492 children and 13 683 x-rays. Box 2
gives the demographic characteristics of the
children and the episodes of care.
1 Hierarchical selection of ICD-9-CM and ICD-10-AM codes for analysis
ICD-9-CM = International classification of diseases, 9th revision, clinical modification. 
ICD-10-AM = International classification of diseases, 10th revision, Australian modification. ◆
Major diagnostic category of diseases of the respiratory system ICD-9-CM Codes 460–519
 ICD-10-AM Codes J00–J99
Acute lower respiratory infections ICD-9-CM Codes 466, 480–487 
 ICD-10-AM Codes J10–J22
Non-viral pneumonias 
(Includes pneumonia unspecified)
ICD-9-CM Codes 481–486 
ICD-10-AM Codes J13–J16, J18
Specified bacterial pneumonias
ICD-9-CM Codes 481–482 
ICD-10-AM Codes J13–J15
Pneumococcal pneumonia
ICD-9-CM Code 481
ICD-10-AM Code J13
Viral pneumonias
Influenza only
ICD-9-CM Code 480 
ICD-10-AM Codes J10–J11
Viral pneumonia excluding 
influenza
ICD-9-CM Code 487
ICD-10-AM Code J12
Bronchiolitis
ICD-9-CM Code 466
ICD-10-AM Code J21
2 Demographic characteristics of children hospitalised and the episodes of care
Characteristic No. (%) children No. (%) episodes
Sex
Male 5 115 (53.9%) 13 281 (55.1%)
Female 4 376 (46.1%) 10 828 (44.9%)
Not specified 1 (0.0) 6 (0.02%)
Total 9 492 (100%) 24 115 (100%)
Age group (months) at the time of admission*
1–11 5 426 (57.2%) 9 997 (41.5%)
12–23 4 432 (46.7%) 7 225 (30.0%)
24–59 4 291 (45.2%) 6 893 (28.6%)
Northern Territory region
Top End 5 887 (62.0%) 13 402 (55.6%)
Centre 3 543 (37.3%) 10 612 (44.0%)
Key comorbidities diagnosed at least once†
Gastrointestinal disorders 4 891 (51.5%) 8 439 (34.9%)
Metabolic disturbance‡ 1 468 (15.5%) 2 319 (9.6%)
Anaemia 3 288 (34.6%) 4 977 (20.6%)
* Individual children may be represented more than once (eg, admitted when aged 1–11 months and 
readmitted when aged 12–23 months).  † Number of episodes of care in which a comorbidity was diagnosed.  
‡ Includes malnutrition, failure to thrive. ◆MJA • Volume 192 Number 10 • 17 May 2010 593
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Overall, in 13 205 episodes of care (54.7%),
irrespective of diagnosis, chest x-rays were
taken within 3 days; endpoint consolidation
was found in 11.6% (1535) of these; film
quality was inadequate in 14.0% (1854).
The 1535 episodes of endpoint consolida-
tion occurred in 1211 children with a range
of 1–16 episodes per child (one episode,
937 children; two or more episodes, 274
children). Median age at the time of admis-
sion was 15 months (range, 1–59 months);
40.8% of episodes were for children aged
< 12 months and 23% were for children
aged < 6 months. Rates were 1.22 times
higher for boys (95% CI, 1.19–1.26;
P < 0.001), and 2.1 times higher in children
in the southern region of NT (Centre) (95%
CI, 1.6–2.8) compared with the Top End
(Box 3). The average annual cumulative
incidence of endpoint consolidation was
26.6 per 1000 population per year (95% CI,
25.3–27.9); 57.5 per 1000 per year in
infants aged 1–11 months, 38.3 per 1000
per year in those aged 12–23 months, and
13.3 per 1000 per year in those aged 24–59
months. Annual rates for each year of the
study by age group are shown in Box 4.
Chest x-rays were taken within 3 days of
admission in 6852 of the 8518 episodes
(80.4%) with any diagnosis in the category,
acute lower respiratory infection (ALRI).
Film quality was inadequate for determining
endpoint consolidation in 1305 (19.0%) epi-
sodes with ALRI. Endpoint consolidation was
diagnosed in 20.4% of episodes with ICD-
defined ALRI (1401/6852); 33.2% with non-
viral pneumonia (1178/3551); 40.4% with
pneumococcal pneumonia (21/52); 13.8%
with influenza (32/232) (of which 3% had a
concomitant diagnosis of non-viral pneumo-
nia); and 9.2% with bronchiolitis (226/2455)
(of which 43% had a concomitant diagnosis
of non-viral pneumonia).
Sixty-four episodes with endpoint consol-
idation had no respiratory diagnosis
recorded (4.2% of endpoint consolidation
episodes). There were 258 diagnoses
attached to these episodes; 59 (22.9%) were
conditions listed under the major diagnostic
category of infectious and parasitic diseases
(predominantly gastrointestinal infections);
55 (21.3%) were haematological and meta-
bolic disorders; 36 (14.0%) were related to
external causes and injury (eg, trauma or
near drowning) and 10 (3.9%) were ear
diseases. The remainder were scattered
across other diagnostic categories. As coding
errors cannot be excluded, these episodes
were included in the analysis.
There were differing seasonal patterns of
endpoint consolidation and other respira-
tory diagnoses between the NT regions.
Episodes of endpoint consolidation were
more frequent in the winter and spring
months in the Central Australian region of
NT; in the Top End region, episodes were
more evenly distributed across the year.
DISCUSSION
We found that the annual incidence of
endpoint consolidation in NT children
under 5 years of age approximates 3%, and
in infants aged under 12 months it is as high
as 7%. Differences in study design, case
ascertainment, and populations complicate
direct comparisons; however, rates of WHO-
defined endpoint consolidation in NT chil-
dren are between three and 25 times higher
than found elsewhere. The rates in children
aged less than 12 months in the Central
Australian region of the NT are the highest
reported in the world.
Case ascertainment differences may par-
tially explain the high rates of endpoint
consolidation we found. First, the entire
NT hospitalised population was included,
and hospital access has been improving
over the past two decades; and, second,
we included remote-living children. Com-
parable data on children in other disad-
vantaged populations are from studies in
predominantly urban or peri-urban popu-
lations; children from rural and remote
areas, with substantially less access to
health services and with differing risk-
factor profiles, would have been missed.
These studies are from The Gambia (53.0/
1000; aged 1–11 months),5 Philippines
(13.5/1000; aged 6 weeks to 23 months),6
Indonesia (8.9/1000;  aged 1.5–23
months),7 Chile (5.0/1000; aged 4–23
months),8 Fiji (4.3/1000; aged 1–59
months),9 Uruguay (up to 16.9/1000;
aged 0–59 months)10 and South Africa
(4.9/1000; aged 1.5–30 months).11 Fur-
thermore, we included all chest x-rays
taken within the first 3 days of admission.
Studies including only x-rays taken on the
day of admission may miss some cases, as
clinical pneumonia may precede radiolo-
gically confirmed endpoint consolidation.
Indigenous children in the NT may have a
different risk factor and health care access
profile, predisposing them to infection and
hospitalisation. Underlying medical condi-
tions or comorbidities (eg, malnutrition,
anaemia and gastrointestinal infections) are
common,12,13 and the high prevalence of
low-birthweight infants is well docu-
mented.14-16 Overcrowding, excessive pneu-
mococci and non-typeable Haemophilus
influenzae carriage rates in early infancy,17,18
and repeated infections leading to bron-
3 Average annual incidence of 
endpoint consolidation per 1000 
population: by Northern Territory 
region and child’s age group
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AT TH E FRONTLINE —  RESEARCHchiectasis and chronic lung disease19,20 may
play an important role in disease burden.
The major limitations of our study were its
retrospective nature, the inclusion of hospital-
ised children only, and the use of a specific
case definition as the primary outcome. The
results should be viewed as an underestimate
of the true incidence of disease. Most children
with ALRI are treated in the community with-
out a chest x-ray and antibiotic use is high.
Measurement error leading to an overesti-
mation of disease incidence is unlikely. All
readers were blinded to the clinical diagnosis
associated with each chest x-ray film. While
readers might have been influenced by know-
ing that they were examining x-rays from a
high-risk population, the incidence of end-
point consolidation found was lower than that
anticipated from a priori estimates based on
data from Central Australia.21 Furthermore,
the proportion of admitted episodes of care
deemed positive for endpoint consolidation
(20% of all episodes of ALRI in which a chest
x-ray was taken) was similar to that reported
in other studies.5,11,22
The rates of pneumonia in Indigenous chil-
dren hospitalised in the NT are among the
highest reported in the world. This is unac-
ceptable in a wealthy country like Australia,
and reducing this disease burden should be a
national priority. Ongoing surveillance pro-
grams incorporating aetiological studies and
innovative interventions are urgently required.
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